JPRN-UMIN000006935招募中2 期
A phase II clinical trial of zoledronic acid treatment for advanced non-small cell lung cancer with bone metastasis. - A phase II clinical trial of zoledronic acid treatment for advanced non-small cell lung cancer with bone metastasis.
Dokkyo Medical University School of Medicine, Department of Pulmonary Medicine and Clinical Immunology0 个研究点目标入组 40 人开始时间: 2011年12月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Hypersensitivity to zoledronic acid 2)Need of emergency treatment for bone metastasis by radiotherapy or surgery 3)Need of treatment for hypercalcemia 4)Prior use of bisphosphonates 5)Symptomatic brain metastasis 6)Active severe infections 7)Severe odontopathy 8)Interstitial pneumonia 9)Active concomitant malignancy 10) Pregnant or lactating 11)Uncontrolled heart disease, hepatic disease,diabetes mellitus, bleeding, etc. 12)Problematic phychiatric deasese 13)Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
2 期
Phase II study of zoledronic acid concomitant with androgen deprivation therapy for patients with treatment-naive bone-metastatic prostate cancerProstate cancerJPRN-UMIN000007548Kinki University52
招募中
2 期
The LoPeZ studyMetastatic non-small cell lung carcinoma with bony metastasesCancer - Lung - Non small cellCancer - BoneACTRN12606000079549Peter MacCallum Cancer Centre14
招募中
2 期
Phase II study of neoadjuvant zoledronic acid therapy for early breast cancer patientsearly breast cancerJPRN-UMIN000003493Division of Medical Oncology and Breast Surgery, Cancer Institute Hospital30
已完成
不适用
Zoledronic acid injection prevents bone loss in spinal cord injury patientsCTRI/2018/03/012408Dr Satyaranjan Sethi60
招募中
2 期
Randomized phase II study of zoledronate administration schedule comparing every 4 weeks versus every 8 weeks for metastatic lung cancer with bone metastasisPrimary lung cancerJPRN-UMIN000009369Institute of Biomedical Research and Innovation210